The identification of treatments that selectively co-inhibit cancerous cell populations remains a challenge. Here, a machine learning approach, scTherapy, leverages single-cell transcriptomic profiles to prioritize multi-targeting treatment options for individual patients with hematological cancers or solid tumors.
- Aleksandr Ianevski
- Kristen Nader
- Tero Aittokallio
